An Estimated 1.2 Million New Vehicles Were Sold in February — a 15% Sequential Increase

RDInvesting Provides Stock Research on Ford and General Motors

Continue Reading

U.S. Food and Drug Administration Approved 30% More Drugs in 2012

RDInvesting Provides Stocks Research on Exelixis and Novogen

Continue Reading

Improvements in the U.S. Economy to Keep Vehicle Sales Climbing in 2013

RDInvesting Provides Stock Research on Honda and Toyota

Continue Reading

Talks of a Potential Merger Between Office Depot and OfficeMax Sends Office Retailers Soaring

RDInvesting Provides Stock Research on Staples and Amazon

Continue Reading

Sharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry-s Success

RDInvesting Provides Stocks Research on ImmunoCellular Therapeutics and Rosetta Genomics

Continue Reading

U.S. Food and Drug Administration Approved 30% More Drugs in 2012

RDInvesting Provides Stocks Research on Ariad Pharmaceuticals and Infinity Pharmaceuticals

Continue Reading

Major Health Insurers Fall on Medicare Rate Cut Proposal

RDInvesting Provides Stock Research on Aetna and WellCare Health Plans

Continue Reading

Humana and UnitedHealth Group Shares Fall as Government Proposes Medicare Advantage Rate Cuts

RDInvesting Provides Stock Research on Humana and UnitedHealth Group

Continue Reading

U.S. Food and Drug Administration Approved 30% More Drugs in 2012 Than the Year Previous

RDInvesting Provides Stocks Research on DARA Biosciences and PDL BioPharma

Continue Reading

Uranium Industry Will Look to Rally in 2013 on the Resurgence of Japanese Demand for Nuclear Power

RDInvesting Provides Stock Research on Uranerz Energy and Paladin Energy

Continue Reading